Register
Statins reduce risk of diabetic retinopathy in patients with type 2 diabetes and dyslipidemia |
Journal Updates
eMediNexus Coverage from: 
Statins reduce risk of diabetic retinopathy in patients with type 2 diabetes and dyslipidemia
eMediNexus,  11 January 2019
remove_red_eye 613 Views
#Diabetes and Endocrinology #Internal Medicine #Ophthalmology

0 Read Comments                

In a cohort study conducted among 37 894 Taiwanese patients with type 2 diabetes and dyslipidemia, those taking statins had a lower rate of diabetic retinopathy and need for treatments for vision-threatening diabetic retinopathy than those not taking statins. When treatment was required, patients taking statins needed a smaller number of interventions than patients not taking statins. These findings are published online in JAMA Ophthalmology online Jan. 10,
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!